Thomas O. Daniel

2012

In 2012, Thomas O. Daniel earned a total compensation of $3.6M as President, Research and Early Development at Celgene.

Compensation breakdown

Non-Equity Incentive Plan$859,993
Option Awards$957,823
Salary$625,000
Stock Awards$1,018,083
Other$97,685
Total$3,558,584

Daniel received $1M in stock awards, accounting for 29% of the total pay in 2012.

Daniel also received $860K in non-equity incentive plan, $957.8K in option awards, $625K in salary and $97.7K in other compensation.

Rankings

In 2012, Thomas O. Daniel's compensation ranked 1,902nd out of 11,487 executives tracked by ExecPay. In other words, Daniel earned more than 83.4% of executives.

ClassificationRankingPercentile
All
1,902
out of 11,487
83rd
Division
Manufacturing
684
out of 4,253
84th
Major group
Chemicals And Allied Products
155
out of 1,203
87th
Industry group
Drugs
87
out of 925
91st
Industry
Pharmaceutical Preparations
72
out of 700
90th
Source: SEC filing on April 30, 2015.

Daniel's colleagues

We found four more compensation records of executives who worked with Thomas O. Daniel at Celgene in 2012.

2012

Robert Hugin

Celgene

Chief Executive Officer

2012

Perry Karsen

Celgene

Chief Executive Officer

2012

Mark Alles

Celgene

Chief Operating Officer

2012

Jacqualyn Fouse

Celgene

President Hematology and Oncology

You may also like